Ruchira(Gupta)GlaserMDMS Clinical Epidemiology & Biostatistics

PubMed

• 267 citations
  Volume-to-creatinine clearance ratio : A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention
  Warren K. Laskey, Charles Jenkins, Faith Selzer, Oscar C. Marroquin, Robert L. Wilensky
  Journal of the American College of Cardiology. 2007-08-14
• 204 citations
  Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention
  Ruchira Glaser, Faith Selzer, David P. Faxon, Warren K. Laskey, Howard A. Cohen
  Circulation. 2005-01-18
• 171 citations
  Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
  Michelle L. O'Donoghue, Ruchira Glaser, Matthew A. Cavender, Philip E. Aylward, Marc P. Bonaca
  JAMA. 2016-04-19

Journal Articles

• Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials  
  Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ; Comparison of Age-related Macular Degeneration Treatments Trials Research ..., Ophthalmology, 1/1/2016
• Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials  
  Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E; Comparison of Age-related Macular Degeneration Treatments Trials Research ..., Ophthalmology, 1/1/2016
• Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial  
  O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ..., JAMA, 1/1/2016
• Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials  
  Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2015
• Rationale and design of the losmapimod To Inhibit p38 MAP kinase as a therapeutic target and modify outcomes after an acute coronary syndrome trial  
  O'Donoghue ML, Glaser R, Aylward PE, Cavender MA, Crisp A, Fox KA, Laws I, Lopez-Sendon JL, Steg PG, Theroux P, Sabatine MS, Morrow DA, Am Heart J, 1/1/2015
• Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimod  
  Barbour AM, Magee M, Shaddinger B, Arya N, Tombs L, Tao W, Patel BR, Fossler MJ, Glaser R, J Clin Pharmacol, 1/1/2015
• Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)  
  Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular D..., Ophthalmology, 1/1/2015
• Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group, Am J Ophthalmol, 1/1/2014
• VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, JAMA Ophthalmol, 1/1/2014
• An effect of moderate hepatic impairment on the pharmacokinetics and safety of darapladib  
  Magee MH, Shearn S, Shaddinger B, Fang Z, Glaser R, Br J Clin Pharmacol, 1/1/2014
• Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials  
  Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2014
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials  
  Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J; Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF; Comparison of AMD Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration  
  Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF; Comparison of Age-related Macular Degeneration Treatme..., Ophthalmology, 1/1/2013
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results  
  Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd, Comparison of Age-related Macular Degeneration Treatments Trials (CAT..., Ophthalmology, 1/1/2012
• Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases  
  Pineles SL, Liu GT, Acebes X, Arruga J, Nasta S, Glaser R, Pramick M, Fogt F, Roux PL, Gausas RE, J Neuroophthalmol, 1/1/2011
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ, N Engl J Med, 1/1/2011
• Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk a...  
  Glaser R, Peacock WF, Wu AH, Muller R, M�ckel M, Apple FS, Am J Cardiol, 1/1/2011
• Drug-eluting or bare-metal stents in ST-elevation myocardial infarction: a growing dilemma or closer to an answer?  
  Glaser R, J Invasive Cardiol, 1/1/2011
• Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)  
  Baldwin DE, Abbott JD, Trost JC, Vlachos HA, Selzer F, Glaser R, Wilensky RL, Slater JN, Doucet S, Naidu SS, Aronow HD, Williams DO, Am J Cardiol, 1/1/2010
• Reply  
  Glaser, Ruchira, J Am Coll Cardiol Intv, 1/1/2009
• Factors associated with poorer prognosis for patients undergoing primary percutaneous coronary intervention during off-hours: biology or systems failure?  
  Glaser R, Naidu SS, Selzer F, et al, J Am Coll Cardiol Intv, 1/1/2008
• New England Journal: Review: Women's Vascular Health  
  Glaser R, New England Journal of Medicine, 1/1/2007
• NHLBI Dynamic Registry Investigators Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after pe...  
  Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR Jr, Journal of the American College of Cardiology, 1/1/2007
• Cost-Effectiveness of Upstream Versus Selective Glycoprotein IIbIIIIa Inhibitors for Acute Coronary Syndromes Reply  
  Glaser R, Glick HA, Herrmann HC, Kimrnel SE, Journal of the American College of Cardiology, 1/1/2007
• Join now to see all

Books/Book Chapters

• Monograph Series Volume 3: Advanced Heart Failure 
  Chapter: Chapter 9 The Role of Cardiac Catheterization in Patients Who have Advanced Heart Failure ISHLT 
  Robert L. Wilensky and Ruchira GlaserEditors: James K. Kirklin, MD, Nicholas Banner, FRCP, and Mariell Jessup, MD.2009
• Textbook of Congestive Heart Failure. 
  Chapter: Hemodynamic Assessment in the Cardiac Catheterization Laboratory. 
  Glaser, R, Kolansky, DEditors: Loh and Jessup.Humana Press2003
• Textbook of Type 2 Diabetes. 
  Chapter: Evaluation of Diabetic Patients for Cardiac and Peripheral Vascular Disease. Chapter 30. 
  Glaser, R, Wiegers SEEditors: Goldstein and Muller-Wieland.Martin Dunitz Ltd2002

Abstracts/Posters

• Women With ST Elevation Myocardial Infarction Treated With Primary PCI Have Worse Outcomes Than Men in the Modern Era: Results From the APEX-AMI Trial.
  Glaser, R, Kaul, P, Roberts, R, Armstrong, PW, Granger, CB, Berdan, LG, Hochman, J, White, Mahaffey, KW, Circulation, 1/1/2009
• A Comparison of Drug-Eluting and Bare-Metal Stents for Saphenous Vein Graft Lesions: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry 2806-4
  Drew E. Baldwin, Jeffrey C. Trost, J. Dawn Abbott, Helen Vlachos, Ruchira Glaser, Robert L. Wilensky, James N. Slater, Nirat Beohar, David O. Williams, JACC, 1/1/2008
• Underutilization of Clopidogrel Pre-treatment in the NHLBI Dynamic PCI Registry: A Missed Opportunity?
  Herbert D. Aronow, Ruchira Glaser, Faith Selzer, J. Dawn Abbott, David O. Williams, Timothy A. Shapiro, Kevin E. Kip, Sheryl F. Kelsey, JACC, 1/1/2008
• TOPIMAGE Registry Results of Feasibility and Safety of IntraVascular MRI for Measurement of Lipid Fraction Index of Coronary Plaque.
  Giora Weisz, Martin B. Leon, Horst Sievert, Jeffrey W. Moses, Stefan Verheye, Ruchira Glaser, Ran Kornowaski, Ron Waksman, Evelyn Regar, Amir Lerman, David halon, Will..., JACC; SCAI/ACC, 1/1/2008
• Five Year Outcomes in a Cohort of Coronary Artery Disease Patients Treated with Percutaneous Coronary Intervention in the NHLBI Dynamic Registry: Initial Acute Coronar...
  Gertz, Z, Wilensky, RL, Selzer,F, Laskey, WK, Marroquin, O, Kip, KE , Glaser, R, Meeting of the American College of Cardiology, New Orleans, LA, 1/25/2007
• Off-hour primary angioplasty: Why is mortality higher?
  Naidu, SS, Wilensky, RL, Selzer, F, Laskey, WK, Srinivas, VS, Slater, JN, Glaser, R, Journal Of The American College Of Cardiology, 1/1/2005
• Incidence, predictors, and sequelae of embolic complications during saphenous vein graft interventions before distal protection device use: An analysis of the NHLBI dy...
  Glaser, R, Selzer, F, Laskey, WK, Cohen, HA, Kelsey, SF, Wilensky, RL, Journal Of The American College Of Cardiology; American College of Cardiology Annual meeting, Orlando, FL, 1/1/2005
• Use of Various Anti-coagulation strategies in the National Heart, Lung, and Blood Institute Dynamic Registry : Patient Profiles and Complications.
  Berkowitz, JM, Glaser, R, Wilensky, RL, Selzer, F, King, SB Srinivas, VS Qureshi, E, Slater, J, Circulation, 1/1/2005
• Treatment of Saphenous Vein Graft Lesions with Drug Eluting Stents: A Report from the National Heart, Lung, and Blood Institute Dynamic Registry.
  Trost, J, Glaser, R, Circulation, 1/1/2005
• Risk of Major Adverse Cardiac Events from Incidental Asymptomatic Lesions Following Culprit Vessel Coronary Intervention: Observations from the NHLBI Dynamic Registry.
  Glaser, R, Selzer, F., Faxon, D., Laskey, WK, Detre, KM, Wilensky, RL, Circulation; American Heart Association Annual Meeting, Orlando, FL, 1/1/2005
• Acute coronary syndrome is associated with poorer outcomes in women undergoing percutaneous coronary intervention than in men: Observations from the NHLBI dynamic regi...
  Glaser, R, Selzer, F, Jacobs, AK, Laskey, WK, Kelsey, SF, Holper, E, Cohen, HA, Wilensky, RL, Circulation; American Heart Association Annual Meeting, New Orleans, LA, 1/26/2004
• Early Use of Small Molecule Platelet Glycoprotein IIb/IIIa Inhibitors for all Acute Coronary Syndrome Patients is Superior to Selective Use of Abciximab for Only Those...
  Glaser, R., Glick, H., Herrmann, H.C., Kimmel, S. E., Meeting of the American College of Cardiology, New Orleans, LA, 1/9/2004
• Early Use of Small Molecule Platelet Glycoprotein IIbIIIIa Inhibitors for all Acute Coronary Syndrome Patients is Superior to Selective Use of Abciximab for Only Those...
  Glaser, R., Glick, H., Herrmann, H.C., Kimmel, S. E., Journal of the American College of Cardiology, 1/1/2004
• Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts.
  Glaser, R., Lu, M., Narula, N., and Epstein, J.A., Department of Medicine Research Day, University of Pennsylvania Medical Center, 1/1/2002
• Benefit of Invasive Strategy for Women with Acute Coronary Syndromes: Observations from the TACTICS-TIM1 18 Trial.
  Glaser, R., Herrmann, H.C., Murphy, S.A., Demopoulos, L.A., DiBattiste, P.M., Cannon, C.P., Braunwald, E., Journal of the American College of Cardiology; Department of Medicine Research Day, University of Pennsylvania Medical Center, 1/1/2002
• Join now to see all

Lectures

• Management of Stable Coronary Artery Disease Patient. 
  Philadelphia, PA - 1/25/2009
• Women With ST Elevation Myocardial Infarction Treated With Primary PCI Have Worse Outcomes Than Men in the Modern Era: Results From the APEX-AMI Trial 
  Orlando, FL - 1/16/2009
• Coronary Revascularization in Women. 
  Rockport, ME - 1/13/2005
• Incidence, Predictors, and Sequelae of Embolic Complications during Saphenous Vein Graft Interventions before Distal Protection Device Use: An Analysis of the NHLBI Dy... 
  Orlando, FL - 1/9/2005
• Is There a Risk to an Early Invasive Strategy in Women With Acute Coronary Syndrome or Are Invasive Tactics Gender Neutral? 
  Orlando, FL - 1/8/2005
• Utilization of Percutaneous Coronary Intervention in Women. 
  Orlando, FL - 1/7/2005
• Preventative Cardiology in Women: Lipid Management, Diet and Exercise. 
  University of Pennsylvania, Philadelphia, PA - 1/1/2005
• Women and Cardiovascular Disease: What We Know and Where We Need to Go. 
  Tucson, AZ - 1/27/2004
• Pathogenesis of atherosclerosis and unstable coronary syndromes. 
  University of Pennsylvania, Philadelphia, PA - 1/23/2004
• Myocardial Infarction in Women. 
  New Orleans, LA - 1/9/2004
• Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects. 
  University of Pennsylvania, Philadelphia, PA - 1/9/2004
• Acute Coronary Syndrome is associated with Poorer Outcomes in Women Undergoing Percutaneous Coronary Intervention than in Men: Observations from the NHLBI Dynamic Regi... 
  New Orleans, LA - 1/8/2004
• Pulmonary Artery Catheters and Hemodynamics 
  1/1/2004
• Ischemic heart disease in women. 
  Absecon, NJ - 1/20/2003
• Risk of Major Adverse Cardiac Events from Incidental Asymptomatic Lesions Following Culprit Vessel Coronary Intervention: Observations from the NHLBI Dynamic Registry. 
  Orlando, FL - 1/12/2003
• Vascular access techniques and complications. 
  University of Pennsylvania, Philadelphia, PA - 1/5/2003
• Benefit of Invasive Strategy for Women with Acute Coronary Syndromes: Observations from the TACTICS-TIMI 18 Trial. 
  Atlanta, GA - 1/16/2002
• Career Pathways in Cardiology for Women. 
  University of Pennsylvania School of Medicine - 1/1/2001
• Join now to see all

Other

• Percutaneous Coronary Intervention in Women. 
  Ananostopoulos, AM, Glaser, R, Business Briefing: Women's Healthcare
  1/1/2005
• Myocardial Infarction in Women. (Interview) 
  Glaser R, ACCEL Educational Series
  New Orleans, LA - 1/1/2004
• Women Treated by PCI for ACS Have Worse Outcomes than Men. (Interview) 
  Glaser R, American Heart Association News
  New Orleans, LA - 1/1/2004
• Flight Passenger with Acute MI. (Interview) 
  Glaser R, ABC News, Philadelphia Affiliate
  1/1/2003
• Women in Acute Coronary Syndromes. (Interview) 
  Glaser R, Planete Cardio CD-ROM
  France - 1/1/2002
• Join now to see all